Former Landmark Health CEO Nick Loporcaro recently joined the Chicago-based private equity firm The Vistria Group as a senior operating partner. Vistria currently counts hospice provider Mission Healthcare in its portfolio. While Mission is Vistria’s only current hospice asset, the firm is a long-time investor in the hospice space. Late last year, Vistria sold Agape […]
Last month, connectRN announced it had raised $76 million, with the Series F round, led by Suvretta Capital Management and Avidity Partners, with other investors including Amedisys Inc. (Nasdaq: AMED). Amedisys did not disclose the size of its investment in connectRN, which has now raised more than $95 million since its 2014 founding. Along with […]
This article is brought to you by Medalogix. The article is based on a live Q&A session with Elliott Wood, President & Chief Executive Officer of Medalogix, which took place at the Hospice News ELEVATE conference in Chicago held on October 21, 2021. The discussion has been edited for clarity. Hospice News: Welcome to our […]
In a changing payment and regulatory environment, hospices are zeroing in on factors such as data collection, effective revenue cycle management and electronic medical record (EMR) interoperability. Providers that are leveraging technology to achieve these aims need to implement these systems carefully, including education for staff, according to Jennifer Maxwell, CEO and co-founder of Maxwell […]
Chicago-based private equity firm The Vistria Group has agreed to recapitalize and invest in the growth of the post-acute data analytics and machine learning companies Muse Healthcare and Medalogix. Joining Vistria as minority investors are the home health and hospice providers LHC Group (NASDAQ: LHCG), Amedisys (NASDAQ: AMED), and Encompass Health (NYSE: EHC). The dollar amount […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
